Mitchell Levine's Insider Trades & SAST Disclosures

Mitchell Levine's most recent trade in Insight Molecular Diagnostics Inc. was a trade of 87,500 Option to Purchase Common Stock done . Disclosure was reported to the exchange on March 15, 2022.

Share

Note

This is a custom search result for pattern Mitchell Levine.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Insight Molecular Diagnost... Board Meeting High Loss High Volume	Mitchell Levine	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2022	87,500	87,500	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost... Board Meeting High Loss High Volume	Mitchell Levine	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2022	87,500	87,500	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost... Board Meeting High Loss High Volume	Mitchell Levine	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 1.17 per share.	15 Mar 2022	25,000	87,080 (0%)	0%	1.2	29,150	Common Stock, no par value
Insight Molecular Diagnost... Board Meeting High Loss High Volume	Mitchell Levine	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2021	20,000	0	-		-	Restricted Stock Units
Insight Molecular Diagnost... Board Meeting High Loss High Volume	Mitchell Levine	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2021	20,000	66,700 (0%)	0%		0	Common Shares, no par value
Insight Molecular Diagnost... Board Meeting High Loss High Volume	Mitchell Levine	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	28 Apr 2021	4,620	62,080 (0%)	0%		0	Common Shares, no par value
Insight Molecular Diagnost... Board Meeting High Loss High Volume	Mitchell Levine	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2021	255,000	255,000	-		-	Employee Stock Option (right to buy)
Insight Molecular Diagnost... Board Meeting High Loss High Volume	Mitchell Levine	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Dec 2020	10,121	46,700 (0%)	0%		-	Common Stock
Insight Molecular Diagnost... Board Meeting High Loss High Volume	Mitchell Levine	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 1.32 per share.	03 Aug 2020	10,000	36,579 (0%)	0%	1.3	13,200	Common Stock, no par value

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades